Current therapeutic agents and anesthetic considerations for diabetes mellitus / 대한마취과학회지
Korean Journal of Anesthesiology
;
: 195-202, 2012.
Artigo
em Inglês
| WPRIM
| ID: wpr-187715
ABSTRACT
As the incidence of diabetes mellitus (DM) continues to increase worldwide, more diabetic patients will be presented for surgery and anesthesia. This increase of DM is a consequence of the rise in new patients of type 2 DM, and is likely attributable to rapid economic development, improved living standards, aging population, obesity, and lack of exercise. The primary goal of management in DM is to delay, or prevent the macro- and microvascular complications by achieving good glycemic control. More understanding of the pathophysiology of DM has contributed to the advance of new pharmacological approaches. In addition to the conventional therapy for DM, glucagon-like peptide-1 (GLP-1) mimetics, dipeptidyl peptidase-4 (DPP-4) inhibitors, thiazolidinediones (TZDs), and insulin analogues are currently available effective hypoglycemic agents for the management of the patients with DM in the perioperative period and also consider the adverse effects of newly introduced agents that need more clinical observations.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Fatores Socioeconômicos
/
Envelhecimento
/
Desenvolvimento Econômico
/
Incidência
/
Tiazolidinedionas
/
Diabetes Mellitus
/
Peptídeo 1 Semelhante ao Glucagon
/
Período Perioperatório
/
Glucose
/
Hipoglicemia
Tipo de estudo:
Guia de Prática Clínica
/
Estudo de incidência
/
Estudo prognóstico
Limite:
Humanos
Idioma:
Inglês
Revista:
Korean Journal of Anesthesiology
Ano de publicação:
2012
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS